| Keeping up with the therapeutic advances in schizophrenia: a review of novel and emerging pharmacological entities |
20 |
| Buying-shopping disorder-is there enough evidence to support its inclusion in ICD-11? |
15 |
| Gilles de la Tourette syndrome as a paradigmatic neuropsychiatric disorder |
13 |
| Group independent component analysis reveals alternation of right executive control network in Internet gaming disorder |
11 |
| Prevalence of suicide attempt and clinical characteristics of suicide attempters with obsessive-compulsive disorder: a report from the International College of Obsessive-Compulsive Spectrum Disorders (ICOCS) |
10 |
| Occupational therapy for functional neurological disorders: a scoping review and agenda for research |
10 |
| Neuroinflammation and cognition across psychiatric conditions |
9 |
| Evaluation of the long-term safety and tolerability of cariprazine in patients with schizophrenia: results from a 1-year open-label study |
8 |
| Long-term safety and tolerability of aripiprazole lauroxil in patients with schizophrenia |
7 |
| Initial validation of a transdiagnostic compulsivity questionnaire: the Cambridge-Chicago Compulsivity Trait Scale |
7 |
| Reward systems and cognitions in Major Depressive Disorder |
7 |
| Cognition, social cognition, and Self-assessment in schizophrenia: prediction of different elements of everyday functional outcomes |
7 |
| State of the science on mild cognitive impairment (MCI) |
7 |
| QTc interval in patients with schizophrenia receiving antipsychotic treatment as monotherapy or polypharmacy |
6 |
| Cognitive impairment in substance use disorders |
6 |
| Long-term functioning outcomes are predicted by cognitive symptoms in working patients with major depressive disorder treated with vortioxetine: results from the AtWoRC study |
6 |
| Dysphagia characteristics in Huntington's disease patients: insights from the Fiberoptic Endoscopic Evaluation of Swallowing and the Swallowing Disturbances Questionnaire |
5 |
| Overlapping dimensional phenotypes of impulsivity and compulsivity explain co-occurrence of addictive and related behaviors |
5 |
| Drug-drug interactions and clinical considerations with co-administration of antiretrovirals and psychotropic drugs |
5 |
| Skin picking disorder: prevalence, correlates, and associations with quality of life in a large sample |
5 |
| Expert Consensus on Screening and Assessment of Cognition in Psychiatry |
5 |
| Assessment in Work Productivity and the Relationship with Cognitive Symptoms (AtWoRC): primary analysis from a Canadian open-label study of vortioxetine in patients with major depressive disorder (MDD) |
5 |
| Emerging treatments for the behavioral and psychological symptoms of dementia |
5 |
| Unpacking the role of self-reported compulsivity and impulsivity in obsessive-compulsive disorder |
5 |
| Dextromethorphan/Bupropion: A Novel Oral NMDA (N-methyl-d-aspartate) Receptor Antagonist with Multimodal Activity |
4 |
| Tardive dyskinesia: motor system impairments, cognition and everyday functioning |
4 |
| Is there enough interest in and pleasure in the concept of depression? The development of the Leuven Affect and Pleasure Scale (LAPS) |
4 |
| High prevalence of prediabetes and metabolic abnormalities in overweight or obese schizophrenia patients treated with clozapine or olanzapine |
4 |
| Treating depressive episodes or symptoms in patients with schizophrenia |
3 |
| Lamotrigine-induced obsessive-compulsive disorder in patients with bipolar disorder |
3 |
| Cognitive remediation in large systems of psychiatric care |
3 |
| Neuronal underpinnings of cognitive impairment and - improvement in mood disorders |
3 |
| Conducting clinical studies targeting cognition in psychiatry: guiding principles and design |
3 |
| Cognitive impairment in major depressive disorder |
3 |
| A biopsychosocial evaluation of the risk for suicide in schizophrenia |
3 |
| Successful switching of patients with acute schizophrenia from another antipsychotic to brexpiprazole: comparison of clinicians' choice of cross-titration schedules in a post hoc analysis of a randomized, double-blind, maintenance treatment study |
3 |
| Systematic review and exploratory meta-analysis of the efficacy, safety, and biological effects of psychostimulants and atomoxetine in patients with schizophrenia or schizoaffective disorder |
3 |
| A study on the correlates of habit reward and fear-related motivations in alcohol use disorder |
3 |
| A systematic review of the heritability of specific psychopathic traits using Hare's two-factor model of psychopathy |
2 |
| Keeping up with the clinical advances: depression |
2 |
| Binge eating disorder revisited: what's new, what's different, what's next |
2 |
| Why is terrorism a man's business? |
2 |
| Peripheral levels of superoxide dismutase and glutathione peroxidase in youths in ultra-high risk for psychosis: a pilot study |
2 |
| Pharmacotherapy of schizophrenia: toward a metabolomic-based approach |
2 |
| Safety, Tolerability, and Efficacy of Desvenlafaxine in Children and Adolescents with Major Depressive Disorder: Results from Two Open-Label Extension Trials |
2 |
| Examining the validity of the ADHD concept in adults and older adults |
2 |
| Clinical characterization of Italian suicide attempters with bipolar disorder |
2 |
| Availability of dopamine transporters and auditory P300 abnormalities in adults with attention-deficit hyperactivity disorder: preliminary results |
2 |
| Altered brain functional networks in Internet gaming disorder: independent component and graph theoretical analysis under a probability discounting task |
2 |
| Cognitive emotional processing across mood disorders |
2 |
